 |
Prescription and Over-the-Counter Drug Product List
23rd Edition
Cumulative Supplement Number 1: January 2004
NOTE: The format for the Monthly Additions/Deletions Drug
Product List has changed as of the July Cumulative Supplement (CS) of the 21st
Edition to mirror the CS. Refer to the CS Preface section 1.5
CUMULATIVE SUPPLEMENT LEGEND.
ACETYLCYSTEINE
>A> INJECTABLE; INTRAVENOUS
>A> ACETADOTE
>A> + CUMBERLAND PHARMS 6GM /30ML(200MG/ML) N21539 001 JAN 23, 2004 JAN NEWA
ALBUTEROL SULFATE
TABLET, EXTENDED RELEASE; ORAL
ALBUTEROL SULFATE
>D> AB PLIVA EQ 4MG BASE N76130 002 SEP 26, 2002 JAN CRLD
>A> + EQ 4MG BASE N76130 002 SEP 26, 2002 JAN CRLD
>D> AB EQ 8MG BASE N76130 003 SEP 26, 2002 JAN CRLD
>A> + EQ 8MG BASE N76130 003 SEP 26, 2002 JAN CRLD
>D> VOLMAX
>D> AB + MURO EQ 4MG BASE N19604 002 DEC 23, 1992 JAN DISC
>A> @ EQ 4MG BASE N19604 002 DEC 23, 1992 JAN DISC
>D> AB + EQ 8MG BASE N19604 001 DEC 23, 1992 JAN DISC
>A> @ EQ 8MG BASE N19604 001 DEC 23, 1992 JAN DISC
AMLODIPINE BESYLATE; ATORVASTATIN CALCIUM
>A> TABLET; ORAL
>A> CADUET
>A> PFIZER EQ 5MG BASE;EQ 10MG BASE N21540 001 JAN 30, 2004 JAN NEWA
>A> EQ 5MG BASE;EQ 20MG BASE N21540 002 JAN 30, 2004 JAN NEWA
>A> EQ 5MG BASE;EQ 40MG BASE N21540 003 JAN 30, 2004 JAN NEWA
>A> EQ 5MG BASE;EQ 80MG BASE N21540 004 JAN 30, 2004 JAN NEWA
>A> EQ 10MG BASE;EQ 10MG BASE N21540 005 JAN 30, 2004 JAN NEWA
>A> EQ 10MG BASE;EQ 20MG BASE N21540 006 JAN 30, 2004 JAN NEWA
>A> EQ 10MG BASE;EQ 40MG BASE N21540 007 JAN 30, 2004 JAN NEWA
>A> + EQ 10MG BASE;EQ 80MG BASE N21540 008 JAN 30, 2004 JAN NEWA
ASCORBIC ACID; BIOTIN; CHOLECALCIFEROL; CYANOCOBALAMIN; DEXPANTHENOL; FOLIC ACID;
NIACINAMIDE; PYRIDOXINE; RIBOFLAVIN; THIAMINE; TOCOPHEROL ACETATE; VITAMIN A; VITAMIN K
INJECTABLE; IV (INFUSION)
>A> INFUVITE PEDIATRIC (PHARMACY BULK PACKAGE)
>A> + SABEX 2002 80MG/VIAL;0.02MG/VIAL;400
IU/VIAL;0.001MG/VIAL;5MG/VIAL;0.14M
G/VIAL;17MG/VIAL;1MG/VIAL;1.4MG/VIA
L;1.2MG/VIAL;7 IU/VIAL;2,300
IU/VIAL;0.2MG/VIAL N21646 001 JAN 29, 2004 JAN NEWA
ASCORBIC ACID; BIOTIN; CYANOCOBALAMIN; DEXPANTHENOL; ERGOCALCIFEROL; FOLIC ACID;
NIACINAMIDE; PYRIDOXINE HYDROCHLORIDE; RIBOFLAVIN PHOSPHATE SODIUM; THIAMINE
HYDROCHLORIDE; VITAMIN A; VITAMIN E; VITAMIN K
INJECTABLE; IV (INFUSION)
>A> M.V.I. ADULT
>A> + AAIPHARMA LLC 200MG/VIAL;0.06MG/VIAL;0.005MG/VIAL
;15MG/VIAL;0.005MG/VIAL;0.6MG/VIAL;
40MG/VIAL;6MG/VIAL;3.6MG/VIAL;6MG/V
IAL;1MG/VIAL;10MG/VIAL;0.15MG/VIAL N21625 001 JAN 30, 2004 JAN NEWA
BETAMETHASONE DIPROPIONATE
CREAM, AUGMENTED; TOPICAL
BETAMETHASONE DIPROPIONATE
>A> AB ATRIX EQ 0.05% BASE N76603 001 JAN 23, 2004 JAN NEWA
BUPROPION HYDROCHLORIDE
TABLET, EXTENDED RELEASE; ORAL
BUPROPION HCL
>A> AB IMPAX LABS 100MG N75913 001 JAN 28, 2004 JAN NEWA
CALCITRIOL
INJECTABLE; INJECTION
CALCITRIOL
>A> AP MAYNE PHARMA USA 0.001MG/ML N75816 001 JAN 16, 2004 JAN NEWA
>A> AP 0.002MG/ML N75816 002 JAN 16, 2004 JAN NEWA
CARBOPLATIN
INJECTABLE; IV (INFUSION)
PARAPLATIN
>A> + BRISTOL MYERS SQUIBB EQ 600MG /60ML(10MG/ML) N20452 004 JAN 15, 2004 JAN NEWA
CEFACLOR
CAPSULE; ORAL
CEFACLOR
>A> AB CARLSBAD EQ 250MG BASE N65146 001 JAN 22, 2004 JAN NEWA
>A> AB EQ 500MG BASE N65146 002 JAN 22, 2004 JAN NEWA
CEFUROXIME SODIUM
INJECTABLE; IM-IV
CEFUROXIME
>A> AB HIKMA FARMACEUTICA EQ 750MG BASE/VIAL N65048 001 JAN 09, 2004 JAN NEWA
INJECTABLE; INJECTION
>A> AP HIKMA FARMACEUTICA EQ 1.5GM BASE/VIAL N65048 002 JAN 09, 2004 JAN NEWA
>A> AP EQ 7.5GM BASE/VIAL N65046 001 JAN 09, 2004 JAN NEWA
CROMOLYN SODIUM
AEROSOL, METERED; INHALATION
INTAL
>D> + AVENTIS 0.8MG/INH N18887 001 DEC 05, 1985 JAN CAHN
>A> + KING PHARMS 0.8MG/INH N18887 001 DEC 05, 1985 JAN CAHN
SOLUTION; INHALATION
>D> AN + AVENTIS PHARMS 10MG/ML N18596 001 MAY 28, 1982 JAN CAHN
>A> AN + KING PHARMS 10MG/ML N18596 001 MAY 28, 1982 JAN CAHN
CYTARABINE
INJECTABLE; INJECTION
>A> CYTARABINE
>A> AP AM PHARM 100MG/ML N76512 001 JAN 15, 2004 JAN NEWA
>D> + MAYNE PHARMA USA 100MG/ML N75383 001 NOV 22, 1999 JAN CFTG
>A> AP + 100MG/ML N75383 001 NOV 22, 1999 JAN CFTG
DILTIAZEM HYDROCHLORIDE
TABLET, EXTENDED RELEASE; ORAL
CARDIZEM LA
>D> + BIOVAIL 120MG N21392 001 FEB 06, 2003 JAN CRLD
>A> 120MG N21392 001 FEB 06, 2003 JAN CRLD
>D> + 180MG N21392 002 FEB 06, 2003 JAN CRLD
>A> 180MG N21392 002 FEB 06, 2003 JAN CRLD
>D> + 240MG N21392 003 FEB 06, 2003 JAN CRLD
>A> 240MG N21392 003 FEB 06, 2003 JAN CRLD
>D> + 300MG N21392 004 FEB 06, 2003 JAN CRLD
>A> 300MG N21392 004 FEB 06, 2003 JAN CRLD
>D> + 360MG N21392 005 FEB 06, 2003 JAN CRLD
>A> 360MG N21392 005 FEB 06, 2003 JAN CRLD
DIVALPROEX SODIUM
TABLET, DELAYED RELEASE; ORAL
DEPAKOTE
>D> + ABBOTT EQ 125MG VALPROIC ACID N18723 003 OCT 26, 1984 JAN CRLD
>A> EQ 125MG VALPROIC ACID N18723 003 OCT 26, 1984 JAN CRLD
>D> + EQ 250MG VALPROIC ACID N18723 001 MAR 10, 1983 JAN CRLD
>A> EQ 250MG VALPROIC ACID N18723 001 MAR 10, 1983 JAN CRLD
DOXEPIN HYDROCHLORIDE
CONCENTRATE; ORAL
DOXEPIN HCL
>A> AA PHARM ASSOC EQ 10MG BASE/ML N75924 001 JAN 15, 2004 JAN NEWA
ERYTHROMYCIN
CAPSULE, DELAYED REL PELLETS; ORAL
ERYC
>D> @ WARNER CHILCOTT 250MG N62338 001 JAN CMFD
>A> AB 250MG N62338 001 JAN CMFD
ERYTHROMYCIN ESTOLATE
SUSPENSION; ORAL
ERYTHROMYCIN ESTOLATE
>D> AB ALPHARMA EQ 125MG BASE/5ML N62353 001 NOV 18, 1982 JAN CTEC
>A> EQ 125MG BASE/5ML N62353 001 NOV 18, 1982 JAN CTEC
>D> AB EQ 250MG BASE/5ML N62409 001 DEC 16, 1982 JAN CRLD
>A> + EQ 250MG BASE/5ML N62409 001 DEC 16, 1982 JAN CRLD
>D> ILOSONE
>D> AB LILLY EQ 125MG BASE/5ML N50010 001 JAN DISC
>A> @ EQ 125MG BASE/5ML N50010 001 JAN DISC
>D> AB + EQ 250MG BASE/5ML N50010 002 JAN DISC
>A> @ EQ 250MG BASE/5ML N50010 002 JAN DISC
ETHINYL ESTRADIOL; NORGESTIMATE
TABLET; ORAL-28
PREVIFEM
>A> AB ANDRX PHARMS 0.035MG;0.25MG N76334 001 JAN 09, 2004 JAN NEWA
FOMIVIRSEN SODIUM
INJECTABLE; INJECTION
VITRAVENE PRESERVATIVE FREE
>D> + NOVARTIS 6.6MG/ML N20961 001 AUG 26, 1998 JAN CAHN
>A> + 6.6MG/ML N20961 001 AUG 26, 1998 JAN CAHN
GENTAMICIN SULFATE
SOLUTION/DROPS; OPHTHALMIC
GARAMYCIN
>D> AT + SCHERING EQ 0.3% BASE N50039 002 JAN CDFR
>A> AT + EQ 0.3% BASE N50039 002 JAN CDFR
GENTAMICIN SULFATE
>A> AT ALTANA EQ 0.3% BASE N65121 001 JAN 30, 2004 JAN NEWA
HYDROCORTISONE BUTYRATE
SOLUTION; TOPICAL
>A> HYDROCORTISONE BUTYRATE
>A> AT TARO PHARM INDS 0.1% N76364 001 JAN 14, 2004 JAN NEWA
LOCOID
>D> + FERNDALE LABS 0.1% N19116 001 FEB 25, 1987 JAN CFTG
>A> AT + 0.1% N19116 001 FEB 25, 1987 JAN CFTG
KETOCONAZOLE
SHAMPOO; TOPICAL
>A> KETOCONAZOLE
>A> AB CLAY PARK 2% N76419 001 JAN 07, 2004 JAN NEWA
NIZORAL
>D> + MCNEIL CONS SPECLT 2% N19927 001 AUG 31, 1990 JAN CFTG
>A> AB + 2% N19927 001 AUG 31, 1990 JAN CFTG
KETOROLAC TROMETHAMINE
INJECTABLE; INJECTION
KETOROLAC TROMETHAMINE
>D> AP BEDFORD 15MG/ML N75222 001 APR 26, 1999 JAN CRLD
>A> AP + 15MG/ML N75222 001 APR 26, 1999 JAN CRLD
>D> AP 30MG/ML N75222 002 APR 26, 1999 JAN CRLD
>A> AP + 30MG/ML N75222 002 APR 26, 1999 JAN CRLD
>D> TORADOL
>D> AP + ROCHE PALO 15MG/ML N19698 001 NOV 30, 1989 JAN DISC
>A> @ 15MG/ML N19698 001 NOV 30, 1989 JAN DISC
>D> AP + 30MG/ML N19698 002 NOV 30, 1989 JAN DISC
>A> @ 30MG/ML N19698 002 NOV 30, 1989 JAN DISC
LITHIUM CARBONATE
TABLET, EXTENDED RELEASE; ORAL
LITHIUM CARBONATE
>A> AB ROXANE 450MG N76691 001 JAN 05, 2004 JAN NEWA
MESNA
INJECTABLE; INTRAVENOUS
MESNA
>A> AP BEDFORD 100MG/ML N75739 001 JAN 09, 2004 JAN NEWA
METFORMIN HYDROCHLORIDE
TABLET, EXTENDED RELEASE; ORAL
GLUCOPHAGE XR
>D> BRISTOL MYERS SQUIBB 500MG N21202 001 OCT 13, 2000 JAN CFTG
>A> AB 500MG N21202 001 OCT 13, 2000 JAN CFTG
METFORMIN HCL
>A> AB IVAX PHARMS 500MG N76545 001 DEC 01, 2003 JAN NEWA
METOLAZONE
TABLET; ORAL
METOLAZONE
>A> AB TEVA 2.5MG N76600 001 JAN 06, 2004 JAN NEWA
>D> MYKROX
>D> + CELLTECH PHARMS 0.5MG N19532 001 OCT 30, 1987 JAN DISC
>A> @ 0.5MG N19532 001 OCT 30, 1987 JAN DISC
METOPROLOL TARTRATE
TABLET; ORAL
METOPROLOL TARTRATE
>A> CARACO 25MG N76670 001 JAN 15, 2004 JAN NEWA
>A> + MYLAN 25MG N76704 001 JAN 16, 2004 JAN NEWA
>A> AB 50MG N76704 002 JAN 16, 2004 JAN NEWA
>A> AB 100MG N76704 003 JAN 16, 2004 JAN NEWA
METRONIDAZOLE
CAPSULE; ORAL
METRONIDAZOLE
>A> AB KALI LABS 375MG N76522 001 JAN 29, 2004 JAN NEWA
MINOCYCLINE HYDROCHLORIDE
TABLET; ORAL
MINOCYCLINE HCL
>D> MEDICIS EQ 50MG BASE N65131 001 APR 16, 2003 JAN CFTG
>A> AB EQ 50MG BASE N65131 001 APR 16, 2003 JAN CFTG
>D> EQ 75MG BASE N65131 002 APR 16, 2003 JAN CFTG
>A> AB EQ 75MG BASE N65131 002 APR 16, 2003 JAN CFTG
>D> + EQ 100MG BASE N65131 003 APR 16, 2003 JAN CFTG
>A> AB + EQ 100MG BASE N65131 003 APR 16, 2003 JAN CFTG
>A> AB RANBAXY EQ 50MG BASE N65156 001 JAN 06, 2004 JAN NEWA
>A> AB EQ 75MG BASE N65156 002 JAN 06, 2004 JAN NEWA
>A> AB EQ 100MG BASE N65156 003 JAN 06, 2004 JAN NEWA
NABILONE
CAPSULE; ORAL
CESAMET
>D> @ LILLY 1MG N18677 001 DEC 26, 1985 JAN CAHN
>A> @ VALEANT 1MG N18677 001 DEC 26, 1985 JAN CAHN
NAPROXEN
TABLET; ORAL
NAPROXEN
>A> AB WESTWARD 250MG N76494 001 JAN 14, 2004 JAN NEWA
>A> AB 375MG N76494 002 JAN 14, 2004 JAN NEWA
>A> AB 500MG N76494 003 JAN 14, 2004 JAN NEWA
NEDOCROMIL SODIUM
AEROSOL, METERED; INHALATION
TILADE
>D> + AVENTIS 1.75MG/INH N19660 001 DEC 30, 1992 JAN CAHN
>A> + KING PHARMS 1.75MG/INH N19660 001 DEC 30, 1992 JAN CAHN
PREDNISONE
TABLET; ORAL
PREDNISONE
>A> AB WEST WARD 2.5MG N40538 001 JAN 08, 2004 JAN NEWA
PROPRANOLOL HYDROCHLORIDE
INJECTABLE; INJECTION
PROPRANOLOL
>A> AP AM PHARM PARTNERS 1MG/ML N75826 001 AUG 31, 2001 JAN NEWA
SOMATROPIN RECOMBINANT
INJECTABLE; INJECTION
SEROSTIM
>D> SERONO 4MG/VIAL N20604 003 JUL 25, 1997 JAN CTEC
>A> BX 4MG/VIAL N20604 003 JUL 25, 1997 JAN CTEC
>D> + 8.8MG/VIAL N20604 004 SEP 06, 2001 JAN DISC
>A> @ 8.8MG/VIAL N20604 004 SEP 06, 2001 JAN DISC
TERBINAFINE
GEL; TOPICAL
LAMISIL
>D> @ NOVARTIS 1% N20846 001 APR 29, 1998 JAN CMFD
>A> 1% N20846 001 APR 29, 1998 JAN CMFD
>A> TIOTROPIUM BROMIDE MONOHYDRATE
>A> CAPSULE; INHALATION
>A> SPIRIVA
>A> + BOEHRINGER INGELHEIM EQ 0.018MG BASE N21395 001 JAN 30, 2004 JAN NEWA
TIZANIDINE HYDROCHLORIDE
TABLET; ORAL
TIZANIDINE HCL
>A> AB TORPHARM EQ 2MG BASE N76533 001 JAN 16, 2004 JAN NEWA
>A> AB EQ 4MG BASE N76533 002 JAN 16, 2004 JAN NEWA
IBUPROFEN
SUSPENSION; ORAL
>A> CHILDREN'S ELIXSURE
>A> TARO 100MG/5ML N21604 001 JAN 07, 2004 JAN NEWA
TABLET, CHEWABLE; ORAL
IBUPROFEN
>A> PERRIGO 50MG N76359 001 JAN 16, 2004 JAN NEWA
>A> 100MG N76359 002 JAN 16, 2004 JAN NEWA
LORATADINE; PSEUDOEPHEDRINE SULFATE
TABLET, EXTENDED RELEASE; ORAL
LORATADINE AND PSEUDOEPHEDRINE SULFATE
>A> ANDRX PHARMS 5MG;120MG N76208 001 JAN 28, 2004 JAN NEWA
 Back
to Top 
Index Page
February 26, 2004 |
|
